AstraZeneca revenue increased from $22.1 billion in 2018 to $24.4 billion in 2019, a 10.4% increase.

Annual Revenue ($)

AstraZeneca revenue was $24.38 b in FY, 2019 which is a 10.4% year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019
Revenue$22.47 b$22.09 b$24.38 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020
Revenue$5.41 b$5.05 b$6.23 b$5.18 b$5.16 b$5.34 b$5.49 b$5.82 b$6.41 b$6.35 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

AstraZeneca revenue breakdown by business segment: 10.3% from Collaboration Revenue, 18.5% from Other Disease Areas, 20.9% from Respiratory, Inflammation and Autoimmunity, 17.9% from Oncology and 32.3% from Cardiovascular and Metabolic Diseases

AstraZeneca revenue breakdown by geographic segment: 20.3% from Continental Europe, 35.4% from Americas, 29.9% from Asia, Africa & Australasia and 14.4% from UK

FY, 2019FY, 2018FY, 2017
Collaboration Revenue819 m1.04 b2.31 b
Other Disease Areas2.60 b3.40 b4.16 b
Respiratory, Inflammation and Autoimmunity5.39 b4.91 b4.71 b
Oncology8.67 b6.03 b4.02 b
Cardiovascular and Metabolic Diseases6.91 b6.71 b7.27 b
FY, 2019FY, 2018FY, 2017
Continental Europe4.16 b380 m4.56 b
Americas9.33 b8.53 b7.96 b
Asia, Africa & Australasia9.07 b7.35 b6.71 b
UK1.82 b2.39 b3.24 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.